drugset / Trial / NCT07487142
Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding"
RandomizedParallel-groupOpen-labelOther
Summary
In the present study, the aim was to report the prevalence of positive H. pylori infection in an unselected population referred for coronary intervention and likely to required DAPT or DPI, also the study assessed impact of H. pylori eradication on occurrence of GI symptoms or bleeding during the follow up period.
Timeline
- Start
- 2024-06-10
- Primary completion
- 2025-12-24
- Completion
- 2025-12-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bismuth Potassium Citrate | Unknown | 300 mg | — |
| Comparator | Bismuth Potassium Citrate | Unknown | 525 mg | — |
| Comparator | Metronidazole | Small molecule | 250 mg | — |
| Comparator | Metronidazole | Small molecule | 500 mg | — |
| Comparator | Omeprazole | Other / unclassified | — | — |
| Comparator | Tetracycline | Unknown | 500 mg | — |